IAG
GILD icon

Investment Advisory Group’s Gilead Sciences GILD Stock Holding History

Investment Advisory Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$265K Buy
2,097
+88
+4% +$11.6K 0.06% 176
2026
Q1 		$280K Buy
2,009
+33
+2% +$4.62K 0.07% 157
2025
Q4 		$243K Buy
1,976
+45
+2% +$5.47K 0.06% 167
2025
Q3 		$214K Hold
1,931
– – 0.06% 180
2025
Q2 		$214K Sell
1,931
-14
-0.7% -$1.49K 0.06% 167
2025
Q1 		$218K Buy
+1,945
New +$201K 0.07% 158

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Investment Advisory Group's GILD Position: Q2 2026 in Review

Investment Advisory Group increased its Gilead Sciences (GILD) stake by 4.4% in Q2 2026, buying an estimated $11.6K and bringing the position to 2,097 shares worth $265K. The position accounts for 0.06% of the portfolio, ranked #176.

Investment Advisory Group first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $280K in Q1 2026. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Investment Advisory Group held 2,097 shares of Gilead Sciences worth $265K as of Q2 2026.
  • Investment Advisory Group bought 88 Gilead Sciences shares in Q2 2026, an estimated $11.6K.
  • Gilead Sciences made up 0.06% of Investment Advisory Group's portfolio in Q2 2026, its #176 holding.
  • Investment Advisory Group first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • Investment Advisory Group's Gilead Sciences position peaked at $280K in Q1 2026.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Investment Advisory Group's 13F filing for Q2 2026, filed 6 Aug 2026.